2005
DOI: 10.1210/jc.2004-2234
|View full text |Cite
|
Sign up to set email alerts
|

The Impact on Clinical Practice of Routine Screening for Macroprolactin

Abstract: Routine screening of all hyperprolactinemic sera for macroprolactin is recommended.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
51
1
1

Year Published

2006
2006
2016
2016

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 131 publications
(63 citation statements)
references
References 36 publications
3
51
1
1
Order By: Relevance
“…Prolactinemia was assessed to evaluate activation of the dopamine pathways. In this study, prolactin was evaluated by electrochemiluminescence immunoassay (ECLIA; Roche Diagnostic) (Fahie-Wilson et al 2000;Gibney et al 2005), as was cortisol (Chiu et al 2003).…”
Section: Stimulation Proceduresmentioning
confidence: 99%
“…Prolactinemia was assessed to evaluate activation of the dopamine pathways. In this study, prolactin was evaluated by electrochemiluminescence immunoassay (ECLIA; Roche Diagnostic) (Fahie-Wilson et al 2000;Gibney et al 2005), as was cortisol (Chiu et al 2003).…”
Section: Stimulation Proceduresmentioning
confidence: 99%
“…Gibney et al demonstrated that screening leads to substantial cost savings by decreasing the number of MRI exams and prescriptions for dopamine agonists [44].…”
Section: Macroprolactinmentioning
confidence: 99%
“…Macroprolactinaemia (MPRL) is the condition which results when the high molecular mass forms (bPRL, bbPRL) are predominant. MPRL is classically associated with asymptomatic hyperprolactinaemia (3,4), though symptoms of hyperprolactinaemia have been described in some macroprolactinaemic patients (5,6,7,8,9). The prevalence of MPRL has been estimated at being between 10 and 45% in the hyperprolactinaemic population (2,5,6,10).…”
Section: Introductionmentioning
confidence: 99%